| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 35 |
| 1 | METHOTREXATE | 33 |
| 2 | CYCLOPHOSPHAMIDE | 19 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 19 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 19 |
| 5 | DEXAMETHASONE | 17 |
| 6 | DEXAMETHASONE 1.5 MG | 17 |
| 7 | BLINATUMOMAB | 16 |
| 8 | ETOPOSIDE | 16 |
| 9 | MITOXANTRONE HYDROCHLORIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOXANTRONE HYDROCHLORIDE | 14 | 0.0022 |
| 1 | CHLOROTHIAZIDE SODIUM | 2 | 0.0022 |
| 2 | GILTERITINIB | 7 | 0.0017 |
| 3 | CHLOROTHIAZIDE | 2 | 0.0016 |
| 4 | BLINATUMOMAB | 16 | 0.0015 |
| 5 | ALFUZOSIN HYDROCHLORIDE | 2 | 0.0008 |
| 6 | PLERIXAFOR | 1 | 0.0007 |
| 7 | INOTUZUMAB OZOGAMICIN | 2 | 0.0007 |
| 8 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 9 | BENDAMUSTINE HYDROCHLORIDE | 5 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 34 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| 2 | Alkylating Drug [EPC] | 19 |
| 3 | Topoisomerase Inhibitor [EPC] | 16 |
| 4 | BCL-2 Inhibitor [EPC] | 14 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 14 |
| 6 | Azole Antifungal [EPC] | 11 |
| 7 | Proton Pump Inhibitor [EPC] | 8 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 7 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 1 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 6 | 0.0003 |
| 3 | BCL-2 Inhibitor [EPC] | 14 | 0.0002 |
| 4 | Topoisomerase Inhibitor [EPC] | 16 | 0.0002 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 3 | 0.0002 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 19 | 0.0001 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 33 | 0.0001 |
| 9 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |